JOHNSON & JOHNSON Holdings

JOHNSON & JOHNSON is an investment fund managing more than 339.82M US dollars. The largest holdings include Fate Therapeutics, Legend Biotech and PROCEPT BioRobotics. In Q4 2021 the fund bought assets of total value of 32.81M US dollars and sold assets of total value of 329.71M US dollars.

$339.82M

portfolio value

-3.00%

quarter

-34.07%

1 year

JOHNSON & JOHNSON portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q4 2021	32810000	329710000

JOHNSON & JOHNSON 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Fate Therapeutics, Inc. Portfolio share: 22.28% Portfolio value: 75.72M Avg. open price: N/A Current price: $20.4 P/L: N/A N/A Q3 2021	share	22.28%	75.72M	N/A	$20.4	N/A	N/A Q3 2021
Biotechnology Legend Biotech Corporation Portfolio share: 19.56% Portfolio value: 66.47M Avg. open price: N/A Current price: $50.99 P/L: N/A N/A Q3 2021	share	19.56%	66.47M	N/A	$50.99	N/A	N/A Q3 2021
Medical Devices PROCEPT BioRobotics Corporation Portfolio share: 10.54% Portfolio value: 35.81M Avg. open price: N/A Current price: $45.58 P/L: N/A Sold -15.18% shares Q3 2022	share	10.54%	35.81M	N/A	$45.58	N/A	Sold -15.18% shares Q3 2022
Medical Devices CVRx, Inc. Portfolio share: 9.60% Portfolio value: 32.61M Avg. open price: N/A Current price: $13.5 P/L: N/A N/A Q3 2021	share	9.60%	32.61M	N/A	$13.5	N/A	N/A Q3 2021
Biotechnology MeiraGTx Holdings plc Portfolio share: 7.17% Portfolio value: 24.37M Avg. open price: N/A Current price: $6.49 P/L: N/A N/A Q3 2021	share	7.17%	24.37M	N/A	$6.49	N/A	N/A Q3 2021
Biotechnology Protagonist Therapeutics, Inc. Portfolio share: 6.08% Portfolio value: 20.64M Avg. open price: N/A Current price: $7.8 P/L: N/A N/A Q3 2021	share	6.08%	20.64M	N/A	$7.8	N/A	N/A Q3 2021
Biotechnology Xencor, Inc. Portfolio share: 5.72% Portfolio value: 19.43M Avg. open price: N/A Current price: $29.54 P/L: N/A N/A Q4 2021	share	5.72%	19.43M	N/A	$29.54	N/A	N/A Q4 2021
Health Information Services Cue Health Inc. Portfolio share: 4.91% Portfolio value: 16.70M Avg. open price: N/A Current price: $3.18 P/L: N/A N/A Q3 2021	share	4.91%	16.70M	N/A	$3.18	N/A	N/A Q3 2021
Biotechnology Fusion Pharmaceuticals Inc. Portfolio share: 3.25% Portfolio value: 11.04M Avg. open price: N/A Current price: $2.36 P/L: N/A N/A Q3 2021	share	3.25%	11.04M	N/A	$2.36	N/A	N/A Q3 2021
Biotechnology Adicet Bio, Inc. Portfolio share: 3.05% Portfolio value: 10.36M Avg. open price: N/A Current price: $20.2 P/L: N/A N/A Q3 2021	share	3.05%	10.36M	N/A	$20.2	N/A	N/A Q3 2021
Biotechnology Arrowhead Pharmaceuticals, Inc. Portfolio share: 2.41% Portfolio value: 8.18M Avg. open price: N/A Current price: $31.87 P/L: N/A Sold -80.36% shares Q3 2022	share	2.41%	8.18M	N/A	$31.87	N/A	Sold -80.36% shares Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 2.27% Portfolio value: 7.73M Avg. open price: N/A Current price: $6.72 P/L: N/A N/A Q3 2021	share	2.27%	7.73M	N/A	$6.72	N/A	N/A Q3 2021
Biotechnology Vor Biopharma Inc. Portfolio share: 1.26% Portfolio value: 4.27M Avg. open price: N/A Current price: $4.72 P/L: N/A N/A Q3 2021	share	1.26%	4.27M	N/A	$4.72	N/A	N/A Q3 2021
Medical Devices Nano-X Imaging Ltd. Portfolio share: 0.65% Portfolio value: 2.20M Avg. open price: N/A Current price: $10.08 P/L: N/A N/A Q4 2021	share	0.65%	2.20M	N/A	$10.08	N/A	N/A Q4 2021
Biotechnology Aldeyra Therapeutics, Inc. Portfolio share: 0.62% Portfolio value: 2.10M Avg. open price: N/A Current price: $6.46 P/L: N/A N/A Q3 2021	share	0.62%	2.10M	N/A	$6.46	N/A	N/A Q3 2021
Health Information Services SomaLogic, Inc. Portfolio share: 0.24% Portfolio value: 815K Avg. open price: N/A Current price: $2.7 P/L: N/A N/A Q3 2021	share	0.24%	815K	N/A	$2.7	N/A	N/A Q3 2021
Biotechnology BiomX Inc. Portfolio share: 0.21% Portfolio value: 725K Avg. open price: N/A Current price: $0.26 P/L: N/A N/A Q3 2021	share	0.21%	725K	N/A	$0.26	N/A	N/A Q3 2021
Biotechnology PhaseBio Pharmaceuticals, Inc. Portfolio share: 0.08% Portfolio value: 283K Avg. open price: N/A Current price: $0.07 P/L: N/A N/A Q3 2021	share	0.08%	283K	N/A	$0.07	N/A	N/A Q3 2021
Biotechnology TRACON Pharmaceuticals, Inc. Portfolio share: 0.04% Portfolio value: 140K Avg. open price: N/A Current price: $1.44 P/L: N/A N/A Q3 2021	share	0.04%	140K	N/A	$1.44	N/A	N/A Q3 2021
Medical Devices Senseonics Holdings, Inc. Portfolio share: 0.02% Portfolio value: 72K Avg. open price: N/A Current price: $1.07 P/L: N/A N/A Q3 2021	share	0.02%	72K	N/A	$1.07	N/A	N/A Q3 2021
Biotechnology Graybug Vision, Inc. Portfolio share: 0.01% Portfolio value: 47K Avg. open price: N/A Current price: $0.63 P/L: N/A N/A Q3 2021	share	0.01%	47K	N/A	$0.63	N/A	N/A Q3 2021
Biotechnology Catalyst Biosciences, Inc. Portfolio share: 0.01% Portfolio value: 34K Avg. open price: N/A Current price: $0.55 P/L: N/A N/A Q3 2021	share	0.01%	34K	N/A	$0.55	N/A	N/A Q3 2021

Showing TOP 22 JOHNSON & JOHNSON's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of JOHNSON & JOHNSON?

The biggest position of the JOHNSON & JOHNSON is Fate Therapeutics, Inc. (FATE) with 22.28% portfolio share worth of 75.73M US dollars.

Top 5 JOHNSON & JOHNSON's holdings represent 69.15% of the portfolio:

Fate Therapeutics, Inc. (FATE) – 22.28%
Legend Biotech Corporation (LEGN) – 19.56%
PROCEPT BioRobotics Corporation (PRCT) – 10.54%
CVRx, Inc. (CVRX) – 9.6%
MeiraGTx Holdings plc (MGTX) – 7.17%

Who is the portfolio manager of JOHNSON & JOHNSON?

The portfolio manager of the JOHNSON & JOHNSON is .

What is the total asset value of the JOHNSON & JOHNSON portfolio?

JOHNSON & JOHNSON total asset value (portfolio value) is 339.82M US dollars.

Who is ?

is the portfolio manager of the JOHNSON & JOHNSON.

What is (JOHNSON & JOHNSON) fund performance?

JOHNSON & JOHNSON's quarterly performance is -3.00%, annualy -34.07%.

What is the JOHNSON & JOHNSON CIK?

JOHNSON & JOHNSON's Central Index Key is 0000200406 .